Exploring Cell Therapies in HER2 Solid Tumors
Time: 9:00 am
day: Day Two
Details:
• Discussing target engagement and response biomarkers
• Targeting tumors, targeted therapies & more
• Exploring T cell Antigen Coupler (TAC) technology
